PubRank

William E Smoyer

Author PubWeight™ 35.99‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Management of childhood onset nephrotic syndrome. Pediatrics 2009 1.87
2 Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: a Midwest Pediatric Nephrology Consortium (MWPNC) study. J Pediatr 2009 1.72
3 Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization. Kidney Int 2005 1.59
4 Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease. Clin J Am Soc Nephrol 2012 1.56
5 Hemodialysis for near-fatal sodium phosphate toxicity in a child receiving sodium phosphate enemas. Pediatr Emerg Care 2014 1.39
6 Treatment outcome of late steroid-resistant nephrotic syndrome: a study by the Midwest Pediatric Nephrology Consortium. Pediatr Nephrol 2013 1.39
7 Significance of hemolysis on extracorporeal life support after cardiac surgery in children. Pediatr Nephrol 2008 1.34
8 Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: prevention by lipoic acid treatment. BMC Nephrol 2006 1.34
9 Management patterns of childhood-onset nephrotic syndrome. Pediatr Nephrol 2009 1.16
10 Enhanced hemolysis in pediatric patients requiring extracorporeal membrane oxygenation and continuous renal replacement therapy. Ann Thorac Cardiovasc Surg 2007 1.15
11 Childhood nephrotic syndrome--current and future therapies. Nat Rev Nephrol 2012 1.02
12 Genetic testing in nephrotic syndrome--challenges and opportunities. Nat Rev Nephrol 2013 0.99
13 Differential proteomic analysis of proteins induced by glucocorticoids in cultured murine podocytes. Kidney Int 2005 0.97
14 Dose- and time-dependent glucocorticoid receptor signaling in podocytes. Am J Physiol Renal Physiol 2010 0.93
15 Induction of antioxidant enzymes in murine podocytes precedes injury by puromycin aminonucleoside. Kidney Int 2004 0.92
16 Enhanced clearance of highly protein-bound drugs by albumin-supplemented dialysate during modeled continuous hemodialysis. Nephrol Dial Transplant 2008 0.92
17 Meeting the demand for pediatric clinical trials. Sci Transl Med 2014 0.90
18 Inhibition of the protein kinase MK-2 protects podocytes from nephrotic syndrome-related injury. Am J Physiol Renal Physiol 2011 0.89
19 Comparison of direct action of thiazolidinediones and glucocorticoids on renal podocytes: protection from injury and molecular effects. Mol Pharmacol 2011 0.87
20 p38 MAPK/HSP25 signaling mediates cadmium-induced contraction of mesangial cells and renal glomeruli. Am J Physiol Renal Physiol 2005 0.85
21 Single and combination toxic metal exposures induce apoptosis in cultured murine podocytes exclusively via the extrinsic caspase 8 pathway. Toxicol Sci 2006 0.84
22 Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome. Pediatr Nephrol 2003 0.84
23 Differential induction of podocyte heat shock proteins by prolonged single and combination toxic metal exposure. Toxicol Sci 2004 0.83
24 Increasing frequency of acute kidney injury amongst children hospitalized with nephrotic syndrome. Pediatr Nephrol 2013 0.83
25 The CTSA mentored career development program: supporting the careers of child health investigators. Clin Transl Sci 2013 0.82
26 Trends in hospitalization characteristics for pediatric nephrotic syndrome in the USA. Clin Nephrol 2012 0.80
27 Clinical presentation and outcome in a cohort of paediatric patients with membranous lupus nephritis. Nephrol Dial Transplant 2007 0.79
28 Healthcare burden of venous thromboembolism in childhood chronic renal diseases. Pediatr Nephrol 2014 0.79
29 Venous thromboembolism in pediatric nephrotic syndrome. Pediatr Nephrol 2013 0.78
30 Crucial roles of the protein kinases MK2 and MK3 in a mouse model of glomerulonephritis. PLoS One 2013 0.77
31 Arterial compliance in adolescents and young adults receiving chronic hemodialysis. Ren Fail 2008 0.77
32 Recent advances in congenital nephrotic syndrome. Curr Opin Pediatr 2004 0.76
33 Antihypertensive prescription in pediatric dialysis: a practitioner survey by the Midwest Pediatric Nephrology Consortium study. Hemodial Int 2009 0.76
34 Trends in pediatric primary membranoproliferative glomerulonephritis costs and complications. Pediatr Nephrol 2012 0.76
35 Clearance of amino acids by hemodialysis in argininosuccinate synthetase deficiency. J Pediatr 2004 0.75
36 A new 'tac' for childhood nephrotic syndrome. Kidney Int 2012 0.75
37 The need for a children's oncology group-oriented approach to advance the care of children with Idiopathic nephrotic syndrome. Clin J Am Soc Nephrol 2009 0.75
38 Nephrotic syndrome: Genetic screening in steroid-resistant nephrotic syndrome. Nat Rev Nephrol 2013 0.75
39 Do declining private insurance coverage rates influence pediatric hospital charging practices? Clin Pediatr (Phila) 2011 0.75
40 Dyslipidaemia in nephrotic syndrome: mechanisms and treatment. Nat Rev Nephrol 2017 0.75
41 Letter from the authors of "Improved Growth in Young Children with Severe Chronic Renal Insufficiency Who Use Specified Nutritional Therapy," which appeared on pages 2418-2426 of the November 2001 issue of JASN. J Am Soc Nephrol 2002 0.75